Cargando…

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures

Mostrar otras versiones (1)

Correction to: British Journal of Cancer (2003) 88, 613–623; doi:10.1038/sj.bjc.66000681

Detalles Bibliográficos
Autores principales:	Philip, R, Campbell, E, Wheatley, D N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394234/ http://dx.doi.org/10.1038/sj.bjc.6601096

Ejemplares similares

Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures
por: Philip, R, et al.
Publicado: (2003)

Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells
por: Wheatley, D N, et al.
Publicado: (2003)

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells
por: Scott, L, et al.
Publicado: (2000)

Arginine deprivation therapy for malignant melanoma
por: Yoon, Jung-Ki, et al.
Publicado: (2012)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

Arginine–Glycine–Aspartic Acid–Polyethylene Glycol–Polyamidoamine Dendrimer Conjugate Improves Liver-Cell Aggregation and Function in 3-D Spheroid Culture [Corrigendum]
Publicado: (2023)

Degradation of AMPK‐α1 sensitizes BRAF inhibitor‐resistant melanoma cells to arginine deprivation
por: Li, Ying‐Ying, et al.
Publicado: (2017)

HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

Deprivation of arginine by recombinant human arginase in prostate cancer cells
por: Hsueh, Eddy C, et al.
Publicado: (2012)

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
por: Phillips, Melissa M., et al.
Publicado: (2013)

Arginine deprivation in KB cells: I. Effect on cell cycle progress
por: Weissfeld, AS, et al.
Publicado: (1977)

Optimizing arginine deprivation for hard-to-treat cancers
por: Khadeir, Ramsay, et al.
Publicado: (2017)

Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
por: Carpentier, Joséphine, et al.
Publicado: (2022)

Bench-to-Bedside Studies of Arginine Deprivation in Cancer
por: Field, George C., et al.
Publicado: (2023)

Correction to“Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication”
Publicado: (2023)

Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
por: Park, I-S, et al.
Publicado: (2003)

Corrigendum to “Interaction between Gallotannin and a Recombinant Form of Arginine Kinase of Trypanosoma brucei: Thermodynamic and Spectrofluorimetric Evaluation”
por: Adeyemi, O. S., et al.
Publicado: (2018)

l-Arginine deprivation impairs Leishmania major-specific T-cell responses
por: Munder, Markus, et al.
Publicado: (2009)

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors
por: Hajji, Nabil, et al.
Publicado: (2022)

Extracellular arginine is required but the arginine transporter CAT3 (Slc7a3) is dispensable for mouse normal and malignant hematopoiesis
por: Yan, Yuhan, et al.
Publicado: (2022)

Continued initiation of DNA synthesis in arginine-deprived Chinese hamster ovary cells
Publicado: (1977)

Arginine deprivation in KB cells. II. Characterization of the DNA synthesized during starvation
Publicado: (1977)

Differential impact of l-arginine deprivation on the activation and effector functions of T cells and macrophages
por: Choi, B.-S., et al.
Publicado: (2009)

Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review
por: Al-Koussa, Houssam, et al.
Publicado: (2020)

EFFECTS OF ARGININE DEPRIVATION, ULTRAVIOLET RADIATION, AND X-RADIATION ON CULTURED KB CELLS : A Cytochemical and Ultrastructural Study
por: Lane, Nancy J., et al.
Publicado: (1965)

BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma
por: Li, Ying-Ying, et al.
Publicado: (2016)

Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
por: Sun, Naihui, et al.
Publicado: (2022)

A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
por: Bean, Gregory R, et al.
Publicado: (2016)

Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion
por: Bishop, Eleanor, et al.
Publicado: (2022)

L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells
por: Nurcahyanti, Agustina DR, et al.
Publicado: (2016)

The Ergogenic Potential of Arginine
por: Campbell, Bill I, et al.
Publicado: (2004)

TBIO-14. CHARACTERISATION OF THE ARGININE PATHWAY ENZYMES IN PAEDIATRIC BRAIN TUMOURS TO DETERMINE SUSCEPTIBILITY TO THERAPEUTIC ARGININE DEPLETION
por: Bishop, Eleanor, et al.
Publicado: (2020)

An Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage Invasion
por: Goldman-Pinkovich, Adele, et al.
Publicado: (2016)

Arginine reverses T cell defects
por: Bashyam, Hema
Publicado: (2008)

Death of Mycobacterium tuberculosis by l-arginine starvation
por: Mizrahi, Valerie, et al.
Publicado: (2018)

Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery
por: Ando, Yu, et al.
Publicado: (2021)

The role of arginine and arginine-metabolizing enzymes during Giardia – host cell interactions in vitro
por: Stadelmann, Britta, et al.
Publicado: (2013)

Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells
por: Wei, Xinlei, et al.
Publicado: (2023)

Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
por: Coulson, J M, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_86ob76i7bk2ssf5rt007rgs7ik